Imperial Valley News Center
Vice President Pence at the 34th Space Symposium
- Details
- Written by White House
Colorado Springs, Colorado - Remarks by Vice President Pence at the 34th Space Symposium:
President Trump Announces Presidential Delegation for the Official Working Visit with Prime Minister Abe of Japan
- Details
- Written by White House
Palm Beach, Florida - President Donald J. Trump today announced the members of the Presidential Delegation for the official Working Visit with Prime Minister Abe of Japan at Mar-a-Lago in Palm Beach, FL, beginning Today.
34 Companies Sign Cybersecurity Tech Accord
- Details
- Written by Patrick Nohe - HashedOut
San Francisco, California - Today, on April 17, Microsoft officially announced the Cybersecurity Tech Accord. This has been a long time coming. At last year’s RSA Conference in San Francisco, Microsoft called for “bold new measures” in the fight to defend an open, free and secure internet. Amid an exponential increase in cybercrime, including the likes of Petya, WannaCry and NotPetya, Microsoft felt it was time to create an accord aimed at protecting technology users the world over.
UC Davis Students Breed Beans for Organic Farming
- Details
- Written by Diane Nelson
Davis, California - Graduate students at the University of California, Davis, have begun field tests on very rare commodities: high-yield, disease-resistant bean varieties that can thrive on organic farms.
Secretary Perdue Applauds President Trump’s Selection for USDA’s Under Secretary for Natural Resources and Environment
- Details
- Written by IVN
Washington, DC - U.S. Secretary of Agriculture Sonny Perdue today applauded President Donald J. Trump’s selection of James Hubbard to be the U.S. Department of Agriculture’s (USDA) Under Secretary for Natural Resources and Environment. Following the announcement, Secretary Perdue issued the following statement:
FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
- Details
- Written by Theresa Eisenman
Washington, DC - The U.S. Food and Drug Administration today approved Crysvita (burosumab), the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia (XLH), a rare, inherited form of rickets. XLH causes low levels of phosphorus in the blood. It leads to impaired bone growth and development in children and adolescents and problems with bone mineralization throughout a patient’s life.
Page 1428 of 3785